RFP: Research on Diagnostic and Treatment of Invasive Mold Disease Grant
Funding Amount
Up to US $80,000
Deadline
Deadline not published
Grant Type
Foundation
Overview
This grant opportunity from Pfizer focuses on improving the diagnosis and treatment of Invasive Mold Disease (IMD), particularly in China. It encourages innovative projects that address clinical unmet needs, enhance early diagnosis, and optimize antifungal treatments to improve patient outcomes. With a funding range of up to $80,000 and a total budget of $434,000, projects can span a maximum of three years, aiming to elevate healthcare professionals' awareness and management of IMD.
Note: grant requests for drug/compound are not in scope of this RFP. Pfizer will not supply formulated study drug nor pure substance.
Project Types and Area of Interest
Potential applicants are encouraged to identify and address the clinical unmet needs for the diagnostic and treatment of invasive mold disease (IMD) to early identify suspicious IMD patients, early kick off antifungal treatment and give appropriate antifungal drugs to improve patient outcomes and the prognosis of IMD, reduce treatment relevant AE and improve outcomes. Also leverage healthcare professionals’ awareness and management of IMD.
Funding Range and Project Length
Individual projects requesting up to $80,000 will be considered. The estimated total available budget related to this RFP is $434,000. Maximum project length is 3 years.Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy), and indirect costs.
What The Pfizer Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 9,306
- Total given
- $23.24M
Focus Areas & Funding Uses
Fields of Work
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$6,600,000 total
Deadline
January 8, 2027
George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health
Amount
$5,300,000 total
Deadline
February 1, 2027
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,000,000 total
Deadline
March 5, 2027
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$1,500,000 total
Deadline
March 5, 2027
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
January 7, 2028
Ready to apply for RFP: Research on Diagnostic and Treatment of Invasive Mold Disease Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found RFP: Research on Diagnostic and Treatment of Invasive Mold Disease Grant. Now let's win it.